Trial Watch - bispecific T cell engagers and higher-order multispecific immunotherapeutics
Over the past decades, cancer immunotherapy has evolved into clinical practice, with bispecific T cell engagers (TCEs) and other higher-order multispecific immunotherapeutics emerging as approaches for precision immune modulation. These engineered antibodies redirect immune effector cells toward tum...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
Taylor & Francis Group
2026-12-01
|
| Sraith: | OncoImmunology |
| Ábhair: | |
| Rochtain ar líne: | https://www.tandfonline.com/doi/10.1080/2162402X.2026.2632421 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|